This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses may be missing. Find their university profile.
Research
Latest papers
Alignment of registered cell therapy trial protocols with regulatory guidance on preclinical evidence: a systematic, cross-sectional, protocol-level analysis.
EBioMedicine · 2026
Adaptive versus fixed designs in confirmatory clinical trials: centering the choice on ethics.
Clinical trials (London, England) · 2026
Risk-Benefit of Phase 2 Monotherapy Trials in Adult Solid Cancers: A Systematic Review and Meta-Analysis.
International journal of cancer · 2026 · senior author
Latest funding
- $598,561
PREGTRIAL (Inclusion of PREgnant and lactatinG people in clinical TRIALs)
CIHR · 2024 · Co-investigator
- $7,908,900
Enabling novel cardiac therapies with pluripotent stem cells
SSHRC · 2022 · Co-investigator
- $390,152
Navigating the Valley of Death: How Evidence is Evaluated in Phase 2 Trial Initiation
CIHR · 2020 · Nominated PI
From the 150 most recent of 156 publications.
Alignment of registered cell therapy trial protocols with regulatory guidance on preclinical evidence: a systematic, cross-sectional, protocol-level analysis.
Jeffers MS, Tangamornsuksan W, Dorus B, Bedford P, Kimmelman J, McIsaac DI, Fergusson DA, Lalu MM
Adaptive versus fixed designs in confirmatory clinical trials: centering the choice on ethics.
Baas S, Pin L, Robertson DS, Bretz F, Cho HJ, Flight L, van der Graaf R, Graham M, Jacko P, Jaki T, Kimmelman J, Manfrin A, Milne R, Mozgunov P, Pallmann P, Parke T, Parmar MKB, Pirard V, Sahan K, Singh JA, Tom BDM, Whittaker JC, Wozniak K, Wright D, Zheng H, London AJ, Sheehan M, Villar SS
Risk-Benefit of Phase 2 Monotherapy Trials in Adult Solid Cancers: A Systematic Review and Meta-Analysis.
Ouimet C, Rosu M, Kimmelman J
Drug approvals in crowded drug classes potentially reflect efficacy overestimates and false positivity: A portfolio analysis of immune checkpoint inhibitor trials.
Carlisle BG, Gönen M, Fernandez L, Del Paggio JC, Kimmelman J
Planned time burden for patients participating in phase 2 cancer trials.
Ouimet C, Iskander R, Nipp R, Kimmelman J
Meta-Analysis of Median Survival Times With Inverse-Variance Weighting.
McGrath S, Yang CH, Kimmelman J, Ozturk O, Steele R, Benedetti A
Early-phase trial efficacy and safety effect estimates regress upon testing in phase 3 trials.
Nelson A, Moyer H, Vigneault K, Fernandez L, Sefranek L, Mauguen A, Kimmelman J
New oncology trial designs and equipoise: Commentary on Heynemann et al.
Kimmelman J
Evaluating the translational value of preclinical models: Available tools and frameworks, challenges and strategies.
Pistollato F, Furtmann F, Straccia M, Avey M, Azilagbetor DM, Camp C, Delaney C, Ferreira GS, Garcia-Bermejo ML, Gastaldello A, Gurusamy K, Holden L, Kimmelman J, Lohse S, Marigliani B, Menon JML, Ritskes-Hoitinga M, Sarasija S, Tagle D, Tripodi IJ, Turner J, Wehling M, Costantino H
Weighing Open Science Against Research Participation Burden in Informed Consent: A Randomized Pilot Study.
Iskander R, Kane P, Sharp M, Kimmelman J
PREGTRIAL (Inclusion of PREgnant and lactatinG people in clinical TRIALs)
Principal investigators: Dayan, Natalie; Devereaux, Philip J; Bérard, Anick
Keywords: Accelerating Clinical Trials; Equity, Diversity And Inclusion; Implementation Science; Pregnancy And Lactation
Enabling novel cardiac therapies with pluripotent stem cells
Principal investigators: Laflamme, Michael
Keywords: Cardiac regeneration; Pluripotent stem cells; Cell manufacturing; Heart failure; Synthetic biology; Tissue engineering; Biomedical imaging; 3D bioprinting; Mathematical modeling; Health technology assessment; Bioethics
Navigating the Valley of Death: How Evidence is Evaluated in Phase 2 Trial Initiation
Principal investigators: Kimmelman, Jonathan
Keywords: Clinical Trials; Drug Development; Human Protections; Research Ethics; Risk / Benefit Evaluation; Supporting Evidence; Trial Protocols; Validity; Vignette Studies
Regulatory, Policy and Ethical Implications of Clinical Trial Portfolios
Principal investigators: Kimmelman, Jonathan
Keywords: Bias; Cancer; Clinical Trials; Drug Regulation; Research Ethics
Translation of Highly Promising Basic Science Research into Clinical Applications: A Systematic Review
Principal investigators: Fergusson, Dean A; Lalu, Manoj M
Keywords: Clinical Translation
Interventions for the Opioid Crisis: A Systematic Review Examining Approaches in the Canadian Context and Vulnerable Sub-Populations
Principal investigators: Eisenberg, Mark J; Johnson, Sonia
Keywords: Clinical; Interventions; Knowledge Translation; Opioid Crisis; Opioid-Related Harms; Policy; Public Health; Systematic Review; Vulnerable Populations
Legalization of Recreational Cannabis Use in Canada: A Knowledge Synthesis
Principal investigators: Eisenberg, Mark J; Abramovici, Hanan
Keywords: Cannabis; Scoping Review
Ethics, Efficiency and Patient Burden in Drug Development
Principal investigators: Kimmelman, Jonathan
Keywords: Clinical Trials; Drug Development; Knowledge Translation; Medical Evidence; Research Ethics; Research Integrity; Risk; Systematic Review; Translational Research; Validity
Can Researchers Predict Trial Outcomes and Feasibility? An Empirical Investigation
Principal investigators: Kimmelman, Jonathan
Keywords: Behavioral Science; Calibration; Clinical Equipoise; Clinical Trials; Drug Development; Forecasting; Recruitment; Research Ethics; Risk
The Clinical, Regulatory, and Ethical Implications of Electronic Cigarettes: A Knowledge Synthesis Grant
Principal investigators: Eisenberg, Mark J; Oliver, Susan
Keywords: Electronic Cigarettes; Ethics; Regulation; Scoping Review; Smoking Cessation; Systematic Review
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Department of Medicine
- Pediatrics
- School of Epidemiology and Public Health
- Medicine
- Biomedical Ethics
- Infectious Diseases
- Nursing
- Other
Co-authors at McGill University, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Dean Fergusson
Department of Medicine
13 shared papers, latest 2024
Andrea Benedetti
Infectious Diseases
4 shared papers, latest 2026
Andrea Benedetti
Faculty
4 shared papers, latest 2026
Timothy Caulfield
Pediatrics
4 shared papers, latest 2018
Karine Vigneault
Nursing
3 shared papers, latest 2026
Natasha Kekre
Department of Medicine
2 shared papers, latest 2024
Jesse Papenburg
Medical Microbiology and Infectious Diseases
2 shared papers, latest 2021
Irina Kudrina
Faculty
2 shared papers, latest 2022
Jesse Papenburg
Pediatrics
2 shared papers, latest 2021
Danielle Rice
Psychiatry & Behavioural Neurosciences
2 shared papers, latest 2020
Ian Shrier
Family Medicine
2 shared papers, latest 2020
Ubaka Ogbogu
Faculty
2 shared papers, latest 2021
Kaveh Shojania
Faculty
1 shared papers, latest 2015
Madeleine Sharp
Neurology and Neurosurgery
1 shared papers, latest 2025
Harold Atkins
Department of Medicine
1 shared papers, latest 2018
Petra Schweinhardt
Faculty
1 shared papers, latest 2015
Raphael Saginur
Department of Medicine
1 shared papers, latest 2015
Janet Rossant
Faculty
1 shared papers, latest 2021
Russell Steele
Mathematics and Statistics
1 shared papers, latest 2026
Glen Hazlewood
Medicine
1 shared papers, latest 2024
Justin Presseau
School of Epidemiology and Public Health
1 shared papers, latest 2019
Dean Fergusson
Medicine
1 shared papers, latest 2013
Marc Carrier
Department of Medicine
1 shared papers, latest 2020
Jean-Simon Diallo
Biochemistry, Microbiology and Immunology
1 shared papers, latest 2019
Jeremy Snyder
Faculty
1 shared papers, latest 2018
Christopher McCabe
Faculty
1 shared papers, latest 2016
Rebecca Auer
Cancer Therapeutics
1 shared papers, latest 2019
Marie Hudson
Psychiatry
1 shared papers, latest 2024
Judy Illes
Medicine/Neurology
1 shared papers, latest 2018
David Moher
School of Epidemiology and Public Health
1 shared papers, latest 2020
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.